HormonaHormonaHormona
  • The Institute
  • Research
  • Teaching
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • Português
  • Español
  • The Institute
  • Research
  • Teaching
  • NEWS
  • PUBLICATIONS
  • CONTACT
  • Português
  • Español

Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?

Autores: Bedoschi G, Turan V, Oktay K.
Publicado em: Curr Breast Cancer Rep. 2013 Dec 1;5(4):302-308.
Clique para leitura: https://www.ncbi.nlm.nih.gov/pubmed/?term=Utility+of+GnRH-agonists+for+Fertility+Preservation+in+Women+With+Operable+Breast+Cancer%3A+Is+It+Protective%3F

Post navigation

← Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. →
© INCT Hormona - Instituto Nacional de Ciência e Tecnologia em Hormônios e Saúde da Mulher

Desenvolvido por Estúdio BASS